By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CureVac GmbH 

Paul-Ehrlich-Str. 15

Tübingen    72076  Germany
Phone: 49-7071-92053-0 Fax: 49-7071-92053-11



Company News
CureVac To Present At The 34th Annual J.P. Morgan Healthcare Conference 12/21/2015 11:48:17 AM
CureVac Banks $110 Million 11/3/2015 6:14:49 AM
IAVI And CureVac Partner To Accelerate Development And Testing Of AIDS Vaccine Candidates 9/10/2015 6:22:25 AM
CureVac Sets Up Shop in Cambridge, Mass. to Expand mRNA Therapies 9/10/2015 5:59:28 AM
CureVac To Present At BioCentury's 22nd Annual NewsMakers In The Biotech Industry Conference 9/3/2015 9:34:32 AM
CureVac Release: Collaboration To Develop mRNA Vaccines Expands 8/4/2015 6:24:45 AM
CureVac Announces Phase I/IIa Clinical Study Data Of Its mRNA Cancer Immunotherapy In Prostate Cancer Published In The Journal For Immunotherapy Of Cancer 7/7/2015 6:25:00 AM
CureVac Announces Study Publication In Molecular Therapy Demonstrating Wide-Ranging Benefits Of Sequence-Optimized, Unmodified mRNAs 6/24/2015 6:39:50 AM
Bill & Melinda Gates Foundation Injects $52 Million Into CureVac 3/5/2015 2:34:09 PM
Boehringer Ingelheim Corporation Will Pay Up To $600 Million For CureVac GmbH Lung Cancer Vaccine 9/18/2014 6:21:48 AM